174 related articles for article (PubMed ID: 18418416)
1. Oral IL-10 gene delivery in a microsphere-based formulation for local transfection and therapeutic efficacy in inflammatory bowel disease.
Bhavsar MD; Amiji MM
Gene Ther; 2008 Sep; 15(17):1200-9. PubMed ID: 18418416
[TBL] [Abstract][Full Text] [Related]
2. Biodegradable microspheres targeting mucosal immune-regulating cells: new approach for treatment of inflammatory bowel disease.
Nakase H; Okazaki K; Tabata Y; Chiba T
J Gastroenterol; 2003 Mar; 38 Suppl 15():59-62. PubMed ID: 12698874
[TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal distribution and in vivo gene transfection studies with nanoparticles-in-microsphere oral system (NiMOS).
Bhavsar MD; Amiji MM
J Control Release; 2007 Jun; 119(3):339-48. PubMed ID: 17475358
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow transplantation ameliorates pathology in interleukin-10 knockout colitic mice.
Bamba S; Lee CY; Brittan M; Preston SL; Direkze NC; Poulsom R; Alison MR; Wright NA; Otto WR
J Pathol; 2006 Jun; 209(2):265-73. PubMed ID: 16550633
[TBL] [Abstract][Full Text] [Related]
5. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
O'Malley BW; Li D; McQuone SJ; Ralston R
Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
[TBL] [Abstract][Full Text] [Related]
6. Non-viral delivery of nuclear factor-kappaB decoy ameliorates murine inflammatory bowel disease and restores tissue homeostasis.
De Vry CG; Prasad S; Komuves L; Lorenzana C; Parham C; Le T; Adda S; Hoffman J; Kahoud N; Garlapati R; Shyamsundar R; Mai K; Zhang J; Muchamuel T; Dajee M; Schryver B; McEvoy LM; Ehrhardt RO
Gut; 2007 Apr; 56(4):524-33. PubMed ID: 16950831
[TBL] [Abstract][Full Text] [Related]
7. Measurement of cytokine mRNA expression in intestinal biopsies of cats with inflammatory enteropathy using quantitative real-time RT-PCR.
Nguyen Van N; Taglinger K; Helps CR; Tasker S; Gruffydd-Jones TJ; Day MJ
Vet Immunol Immunopathol; 2006 Oct; 113(3-4):404-14. PubMed ID: 16879876
[TBL] [Abstract][Full Text] [Related]
8. IL-10 gene therapy prevents TNBS-induced colitis.
Lindsay J; Van Montfrans C; Brennan F; Van Deventer S; Drillenburg P; Hodgson H; Te Velde A; Sol Rodriguez Pena M
Gene Ther; 2002 Dec; 9(24):1715-21. PubMed ID: 12457286
[TBL] [Abstract][Full Text] [Related]
9. Effect of Bacillus subtilis PB6, a natural probiotic on colon mucosal inflammation and plasma cytokines levels in inflammatory bowel disease.
Selvam R; Maheswari P; Kavitha P; Ravichandran M; Sas B; Ramchand CN
Indian J Biochem Biophys; 2009 Feb; 46(1):79-85. PubMed ID: 19374258
[TBL] [Abstract][Full Text] [Related]
10. Solid lipid nanoparticles as anti-inflammatory drug delivery system in a human inflammatory bowel disease whole-blood model.
Serpe L; Canaparo R; Daperno M; Sostegni R; Martinasso G; Muntoni E; Ippolito L; Vivenza N; Pera A; Eandi M; Gasco MR; Zara GP
Eur J Pharm Sci; 2010 Mar; 39(5):428-36. PubMed ID: 20138213
[TBL] [Abstract][Full Text] [Related]
11. Oral TNF-α gene silencing using a polymeric microsphere-based delivery system for the treatment of inflammatory bowel disease.
Kriegel C; Amiji M
J Control Release; 2011 Feb; 150(1):77-86. PubMed ID: 20959130
[TBL] [Abstract][Full Text] [Related]
12. 5-amino salicylic acid bound nanoparticles for the therapy of inflammatory bowel disease.
Pertuit D; Moulari B; Betz T; Nadaradjane A; Neumann D; Ismaïli L; Refouvelet B; Pellequer Y; Lamprecht A
J Control Release; 2007 Nov; 123(3):211-8. PubMed ID: 17889397
[TBL] [Abstract][Full Text] [Related]
13. 5-Lipoxygenase-derived lipid mediators are not required for the development of NSAID-induced inflammatory bowel disease in IL-10-/- mice.
Narushima S; DiMeo D; Tian J; Zhang J; Liu D; Berg DJ
Am J Physiol Gastrointest Liver Physiol; 2008 Feb; 294(2):G477-88. PubMed ID: 18048478
[TBL] [Abstract][Full Text] [Related]
14. [Studies on the influence of Candida fungal colonization on the healing process of inflammatory lesions in the colon in rat animal model].
Zwolińska-Wcisło M; Brzozowski T; Budak A; Sliwowski Z; Drozdowicz D; Kwiecień S; Trojanowska D; Rudnicka-Sosin L; Mach T; Konturek SJ; Pawlik WW; Targosz A
Przegl Lek; 2007; 64(3):124-9. PubMed ID: 17941462
[TBL] [Abstract][Full Text] [Related]
15. Identification of adeno-associated viral vectors suitable for intestinal gene delivery and modulation of experimental colitis.
Polyak S; Mach A; Porvasnik S; Dixon L; Conlon T; Erger KE; Acosta A; Wright AJ; Campbell-Thompson M; Zolotukhin I; Wasserfall C; Mah C
Am J Physiol Gastrointest Liver Physiol; 2012 Feb; 302(3):G296-308. PubMed ID: 22114116
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic potency of IL2-caspase 3 targeted treatment in a murine experimental model of inflammatory bowel disease.
Shteingart S; Rapoport M; Grodzovski I; Sabag O; Lichtenstein M; Eavri R; Lorberboum-Galski H
Gut; 2009 Jun; 58(6):790-8. PubMed ID: 18978179
[TBL] [Abstract][Full Text] [Related]
17. Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease.
Lamprecht A; Ubrich N; Yamamoto H; Schäfer U; Takeuchi H; Maincent P; Kawashima Y; Lehr CM
J Pharmacol Exp Ther; 2001 Nov; 299(2):775-81. PubMed ID: 11602694
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut.
Caruso R; Sarra M; Stolfi C; Rizzo A; Fina D; Fantini MC; Pallone F; MacDonald TT; Monteleone G
Gastroenterology; 2009 Jun; 136(7):2270-9. PubMed ID: 19505427
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effect of intratracheal administration of murine IL-4 receptor antagonist on asthmatic airway inflammation.
Tian D; Fu Z; Liu E; He Y; Wang X; Wang L
J Asthma; 2008 Oct; 45(8):715-21. PubMed ID: 18951266
[TBL] [Abstract][Full Text] [Related]
20. Amelioration of established collagen induced arthritis by systemic IL-10 gene delivery.
Fellowes R; Etheridge CJ; Coade S; Cooper RG; Stewart L; Miller AD; Woo P
Gene Ther; 2000 Jun; 7(11):967-77. PubMed ID: 10849557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
